Algo version: 0.98b
UCB SA is listed at the OTC Exchange
UCB SA [UCBJY]
OTC Sector: Healthcare Industry:Biotechnology

Is UCB SA stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, UCB SA pays dividends. Last time was Wednesday 15th of May 2024 where the investors holding the stock on Friday 26th of April 2024 were paid $0.45961 per share. Over the last 12 times between 2013 and 2024, UCB SA has paid $9.13793 with an average of $0.76 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for UCB SA 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $37.10, you would have made a profit of $51.81 per share or 139.65%

Yes, the average daily trading liquidity for UCB SA is $16 282 thousand. You should therefore be able to get in and out of your positions relatively fast.

UCB SA has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.33, the company's ability to pay off the debt is normal. UCB SA has a good net profit margin of 6.56% and should have high tolerances against inflation.

We have calculated the inflation risk for UCB SA to be low [0.4 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.